Monitor Quote Charts Trades News Financials Toplists Alerts Portfolio Level 2 Forex Boards   21/11/2009 21:52:58 Site map   Help   Financials Sector Sheet Search by Sector FilterX For help & enquiries: 1-888-99-ADVFN (toll free)

Immupharma Company Financial Information Immupharma share price | Immupharma company information | Immupharma Share Charts | Immupharma Share News  Company name:  Immupharma  EPIC:  IMM  Trading Currency:  GBX  Market Sector:  ASM7  ISIN:  GB0033711010  Market Segment:  AMSM  Share Type:  DE  WWW Address:  http://www.immupharma.com  Description:  ORD 10P  Industry Sector:  GENERAL RETAILERS  Price  Price Change [%]  Bid  Ask  Open  High  Low  Volume  107.00   -2.75 [-2.51]  106.00  107.75  110.00  112.00  106.00  565,770  Market Cap. [m]  Shares In Issue [m]  Beta  EPS  DPS  PE Ratio  Yield  52-Wks-Range  82.90  77.48  0.50  6.23  -  17.17  -  144.00 - 35.50 Immupharma Key Figures (at previous day's close) Market Cap. 82.90 m Shares In Issue 77.48 m Prev. Close 109.75 PE Ratio 17.17   Dividend Yield - % EPS - basic 6.23 p Dividend PS - p Dividend Cover -   Cash Flow PS -4.60 p Return On Equity (ROE) 41.61 % Operating Margin 8,514.84 % PEG Factor -   EPS Growth Rate - % Dividends PS Growth Rate - % Net Debt -10.30 m Gross Gearing 16.13 % Quick Assets 12.58 m Net Working Capital 11.19 m Intangibles / Fixed Assets 98.38 % Turnover PS 0.07 p Pre-Tax Profit PS 6.28 p Retained Profit PS 6.04 p Cash PS 16.08 p Net Cash PS 14.29 p Net Tangible Asset Value PS * 13.46 p Net Asset Value PS 14.51 p Spread 1.75 (1.62%)   * Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies. Immupharma Balance Sheet Immupharma Share Price Sample Period † High Low 1 week 144.00 104.00 4 weeks 144.00 104.00 12 weeks 144.00 78.00 1 year 144.00 35.50 Immupharma Share Price (5 years) Immupharma Historic Returns Giorni da oggi † Open Change % Open Avg. Avg. Daily Vol [m] Total Vol [m] VWAP 1 week 117.00 -10.00 -8.55 121.30 0.81 - 114.47 4 weeks 110.00 -3.00 -2.73 113.41 0.40 - 112.64 12 weeks 84.00 23.00 27.38 99.78 0.23 - 106.53 26 weeks 84.00 23.00 27.38 92.85 0.46 - 94.15 1 year 37.50 69.50 185.33 81.83 0.33 - 89.85 3 years 67.50 39.50 58.52 70.33 0.13 - 87.06 5 years 37.50 69.50 185.33 62.12 0.08 - 86.39 † periods calculated are whole weeks rather than calendar months Immupharma Key Management Ratios Immupharma Investment Ratios (Market value analysis) at previous day's close PQ Ratio -   PE Ratio 17.17   Tobin's Q Ratio 9.47   Tobin's Q Ratio (excl. intangibles) 10.40   Dividend Yield - % Market-to-Book Ratio 7.38   Price-to-Pre-Tax Profit PS 17.05   Price-to-Retained Profit PS 17.72   Price-to-Cash Flow PS -23.26   Price-to-Sales PS 1,451.42   Price-to-Net Tangible Asset Value PS 7.95   Price-to-Cash PS 6.65   Net Working Capital PS 14.45   Price Pct to Working Capital PS 7.41 % Earnings Yield 5.82 % Average PE 71.94   Years in average 2   PE to PE average 23.88 % Immupharma Financial Ratios (Leverage Ratios) Debt Ratio 6.46 % Debt-to-Equity Ratio 0.07   Debt-to-Equity Ratio (excl. Intgbl) 0.07   Debt-to-Equity Market Value 0.01   Net Gearing -76.83 % Net Gearing (excl. Intangibles) -81.77 % Gross Gearing 16.13 % Gross Gearing (excl. Intangibles) 17.16 % Gearing Under 1 Year 10.34 % Gearing Under 1 Year (excl. Intgbl) 11.00 % Assets/Equity 1.19   Cash/Equity 110.84   (Liquidity Ratios) Net Working Capital to Total Assets 83.53 % Current Ratio 9.08   Quick Ratio (Acid Test) 9.08   Liquidity Ratio 8.99   Cash & Equiv/Current Assets 99.04 % (Solvency Ratios) Enterprise Value 71.22 m CFO/Sales -62.40   CFO/Attributable Profit -   CFO/Assets -0.27   CFO/Debt -1.65   Total Debt/Equity Market Value 0.03   Total Debt/Sales 37.84   Total Debt/Pre-Tax Profit 0.44   Total Debt 2.16 m Total Debt/Net Current Assets 0.19 % (Dodds - Graham Ratios) 3 yr Compound Earnings Growth - % 5 yr Compound Earnings Growth 76.86 % 10 yr Compound Earnings Growth - % Earn drops > 5% in 10yrs 2   Beta (60-Mnth) Beta (36-Mnth) 0.5014 0.3999 Alpha (60-Mnth) Alpha (36-Mnth) 0.0273 0.0294 Immupharma Operating Ratios (Profitability Ratios) Return On Capital Employed (ROCE) 40.48 % Return On Assets (ROA) 53.45 % Net Profit Margin 8,188.83 % Assets Turnover 0.01   Return On Equity (ROE) 41.61 % Return On Investment (ROI) 60.70 % Dividend Payout Ratio - % Plowback Ratio 100.00 % Growth from Plowback Ratio 65.46 % Net Income Of Revenues 8,188.83 % (Asset Utilisation Multiples) Shareholders Equity Turnover 0.01   Fixed Assets Turnover 0.07   Current Assets Turnover 0.01   Net Working Capital Turnover -   Inventory Turnover -   (Other Operating Ratios) Total Assets-to-Sales 153.20   Debtors-to-Sales 442.61 % Debt Collection Period 1,615.53 Days Immupharma Dividends Announcement Date Type Curr. Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount - Final GBP - 12/31/2005 12/31/2006 - - - - - Final GBP - 03/31/2005 03/31/2006 - - - - - Final GBP - 03/31/2004 03/31/2005 - - - - - Final GBP - 02/28/2003 03/31/2004 - - - - Immupharma Fundamentals   31 Mar 2006 (GBP) 31 Dec 2006 (GBP) 31 Dec 2007 (GBP) 31 Dec 2008 (GBP) turnover 0.03 100.00% 0.04 100.00% 0.06 100.00% 0.06 100.00% m pre tax profit -2.48 -9,774.36% -1.91 -4,272.28% -3.34 -5,278.64% 4.86 8,514.84% m attributable profit -2.48 -9,771.25% -1.86 -4,150.20% -3.08 -4,877.94% 4.68 8,188.83% m retained profit -2.48 -9,771.25% -1.86 -4,150.20% -3.08 -4,877.94% 4.68 8,188.83% m eps - basic -4.16   -2.72   -4.24   6.23   eps - diluted -4.16   -2.72   -4.24   5.72   dividends per share -   -   -   -   Immupharma Balance Sheet   31 Mar 2006 (GBP) 31 Dec 2006 (GBP) 31 Dec 2007 (GBP) 31 Dec 2008 (GBP)   31 Mar 2006 (GBP) 31 Dec 2006 (GBP) 31 Dec 2007 (GBP) 31 Dec 2008 (GBP) ASSETS  fixed assets 0.01 0.33% 0.01 0.16% 0.01 0.31% 0.01 0.10% m  intangibles 0.77 21.09% 0.75 10.22% 0.76 18.42% 0.81 6.04% m  fixed investments - -% - -% - -% - -% m  current assets - other - -% - -% - -% - -% m  stocks - -% - -% - -% - -% m  debtors 0.16 4.34% 0.10 1.42% 0.38 9.38% 0.12 0.90% m  cash & securities 2.69 74.24% 6.46 88.20% 2.95 71.88% 12.46 92.96% m TOTAL 3.63 100% 7.32 100% 4.10 100% 13.40 100% m LIABILITIES  creditors - short 1.12 30.97% 1.03 14.13% 0.70 17.17% 1.39 10.34% m  creditors - long - -% 0.40 5.51% 0.35 8.43% 0.78 5.79% m  creditors - other - -% - -% - -% - -% m  subordinated loans - -% - -% - -% - -% m  insurance funds - -% - -% - -% - -% m TOTAL 1.12 30.97% 1.44 19.64% 1.05 25.59% 2.16 16.13% m EQUITY  ord cap, reserves 2.50 69.03% 5.89 80.36% 3.05 74.41% 11.24 83.87% m  prefs, minorities - -% - -% - -% - -% m TOTAL 2.50 69.03% 5.89 80.36% 3.05 74.41% 11.24 83.87% m OTHER NAV Basic -   -   -   -   NAV Diluted -   -   -   -   Immupharma Cash Flow Statement 31 Mar 2006 (GBP) 31 Dec 2006 (GBP) 31 Dec 2007 (GBP) 31 Dec 2008 (GBP) Operating CF -0.88 -1.24 -3.77 -3.56 m Pre-Financing CF -0.27 -1.18 -3.44 -3.47 m Retained CF 2.69 3.77 -3.51 9.51 m Immupharma Brokers Name Activity Type Mnemonic Code Kbc Peel Hunt Ld Market Maker(MME) Broker/Dealer KBC KBCSGB21BIC Panmure Gordon (uk) Limited Market Maker(MME) Broker/Dealer PMUR PMURGB2L Teather & Greenwood Ld Market Maker(MMF) Broker/Dealer TEAM TGREGB21 Winterflood Secs Ld Market Maker(MME) Broker/Dealer WINS WNTSGB2LBIC

LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes. All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs

ADDITIONAL SERVICES AVAILABLE FROM ADVFN ADVFN Forex Channel Exchange Rates, FX Prices Charts, Forex Brokers & Currency Conversion

34 site:2us lse imm091121 21:52 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )